Company / Operating Income
IQVIA Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$2.2B
FY2025
5-year range
$731.0M / $2.2B
FY2021-FY2025
Trend
-0.9%
vs FY2024
Sector context
#19 of 156
Health Care
What the data says
IQVIA's operating income of $2.2B is higher than 88% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 10 years, ranging from $576M in FY2018 to $2.2B in FY2024.
Based on SEC 10-K filings.
$2.2B in FY2025 with a 5-year CAGR of +24.1%. Top quartile in the Health Care sector.
Improved from $2.0B to $2.2B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +44.0%
- 5-Year CAGR
- +24.1%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 156This company $2.2B Sector average $733.1M
▼
+197.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +24.1%, indicating consistent growth.
- In FY2025, operating income decreased 0.9% year-over-year.
- Ranks #19 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 20.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.2B | -0.9% |
| FY2024 | $2.2B | +11.4% |
| FY2023 | $2.0B | +170.5% |
| FY2022 | $731.0M | -5.9% |
| FY2021 | $777.0M | +4.9% |
| FY2020 | $741.0M | +11.4% |
| FY2019 | $665.0M | +15.5% |
| FY2018 | $576.0M | -13.4% |
| FY2017 | $665.0M | +15.5% |
| FY2016 | $576.0M | -10.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026